Gene Editing Market to Reach $7.59 Billion by 2029, Driven by Expanding Applications in Drug Discovery and Advanced Genomic Technologies
According to MarketsandMarkets™, The global Gene Editing Market is projected to grow from USD 4.66 billion in 2024 to USD 7.59 billion by 2029, at a CAGR of 10.2% during the forecast period. Market growth is fueled by rapid advancements in gene editing technologies and the expanding range of applications across drug discovery, cell line development, and genomic research.
Browse 636 market data Tables and 65 Figures spread through 497 Pages and in-depth TOC on “Gene Editing Market “.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000
Increasing investments by pharmaceutical and biotechnology companies, coupled with growing adoption of gene editing tools in academic and research institutions, are accelerating innovation in this space. However, challenges related to scalability and manufacturing of gene-edited products continue to pose constraints on market expansion.
Products Segment Leads Market by Offering
By offering, the products segment accounted for the largest share of the gene editing market in 2023. This segment includes kits, reagents, libraries, and software used across various gene editing workflows.
The strong demand for these products is driven by their critical role in enabling research and experimentation in drug discovery and cell line development. Pharmaceutical companies, biotech firms, and research organizations rely heavily on these tools to conduct gene editing experiments efficiently and at scale.
Drug Discovery & Development Segment Dominates Applications
By application, the drug discovery & development segment held the largest share of the gene editing services market in 2023. The growing focus on developing gene therapies for diseases such as cancer, blood disorders, and central nervous system (CNS) conditions is a key factor driving this segment.
Gene editing technologies are increasingly being used to identify novel drug targets, validate therapeutic approaches, and accelerate the development of precision medicines. This trend is expected to continue as companies intensify their efforts to bring advanced therapies to market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231037000
North America Maintains Market Leadership
North America accounted for the largest share of the gene editing market in 2023, supported by strong research infrastructure, high R&D investments, and increasing approvals of advanced gene therapies.
The presence of leading biotechnology companies and academic institutions, along with favorable regulatory frameworks, continues to drive innovation in the region. Meanwhile, Asia Pacific is expected to witness the fastest growth during the forecast period, driven by increasing genomics research, expanding healthcare infrastructure, and rising adoption of advanced technologies.
Competitive Landscape
Key players operating in the gene editing market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript (US), Agilent Technologies, Inc. (US), Revvity (US), Lonza (US), Tecan Trading AG (Switzerland), Sangamo Therapeutics (US), Precision BioSciences (US), Cellectis S.A. (France), Regeneron Pharmaceuticals Inc. (US), AMSBIO (UK), Creative Biogene (US), Synthego (US), Takara Bio Inc. (Japan), Bio-Techne (US), Caribou Biosciences, Inc. (US), Bioneer Corporation (South Korea), and REPROCELL Inc. (Japan), among others.
These companies are actively focusing on product innovation, strategic collaborations, and expanding service offerings to strengthen their market presence and address evolving customer needs.
Related Reports:
Genomics Market – Global Forecast to 2030
Next-generation Sequencing Market – Global Forecast to 2031
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html
